News

Dalbavancin will be commercialized in Italy, Spain, Poland, Portugal, many Eastern European countries, Russia, Turkey and Commonwealth of Independent States. As part of the deal, Durata will receive

The company has entered into an agreement with Sandoz Canada, pursuant to which the latter will produce, use, sell, market and distribute Olanzapine injection in Canada. InnoPharma president

The clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of Incyte’s oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360, in combination with Genentech’s PD-L1 immune checkpoint

In many countries, aflibercept solution for injection has already been approved as EYLEA to treat patients with neovascular age-related macular degeneration (wet AMD) and visual impairment due to

These broadly neutralizing antibodies (bNAbs) were discovered in collaboration with the International AIDS Vaccine Initiative (IAVI) and The Scripps Research Institute using Theraclone’s proprietary I-STAR technology. The I-STAR

This open-label trial will enroll 10-15 patients who will receive two bertilimumab infusions, at a dose of 10 mg/kg, on days 0 and 14. Patients will also start

Penn Pharma is headquartered in Tredegar, Wales in the United Kingdom and operates regional offices in New Hope, Pennsylvania and Tokyo, Japan. Penn Pharma offers both drug development

Management will also quickly add new high-demand products that have been requested by buyers to round out the TapouT Muscle Growth and Recovery line. In a joint statement

The CHMP positive opinion will be reviewed by the European Commission which, should they affirm the CHMP opinion, will grant a centralized marketing authorization with unified labeling that